Skip to main content

Table 1 Baseline characteristics of CAD and control groups

From: A genetic variant c.553G > T (rs2075291) in the apolipoprotein A5 gene is associated with altered triglycerides levels in coronary artery disease (CAD) patients with lipid lowering drug

 

CAD (354)

Control (377)

P-value

Age (years)

58.52 ± 11.10

37.3 ± 14.7

0.000

Gender (Male/ Female)

235/119

246/131

0.9009

Hypertension (n)

1.31 ± 0.51

1.78 ± 0.41

0.001

Glucose (mmol/ l)

1.39 ± 0.53

1.82 ± 0.38

0.000

HDL-C (mmol/ l)

1.37 ± 0.56

1.46 ± 0.63

0.103

LDL-C (mmol/ l)

1.65 ± 0.96

1.55 ± 0.80

0.191

Chol-C (mmol/ l)

1.17 ± 0.46

1.10 ± 0.36

0.041

TG-C (mmol/ l)

1.51 ± 0.82

1.16 ± 0.46

0.000